Cargando…
The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction
Type 2 diabetes (T2D) is a recognized risk factor for acute coronary syndromes. There is currently no consensus concerning the intensification of antihyperglycemic treatment. According to the available guidelines, it seems that the goal is to achieve glycated hemoglobin (HbA(1c)) levels below 7% and...
Autores principales: | Birkner, Katarzyna, Hudzik, Bartosz, Gąsior, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519839/ https://www.ncbi.nlm.nih.gov/pubmed/28747945 http://dx.doi.org/10.5114/kitp.2017.68744 |
Ejemplares similares
-
Prognostic impact of multimorbidity in patients with type 2 diabetes and ST-elevation myocardial infarction
por: Hudzik, Bartosz, et al.
Publicado: (2017) -
Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction
por: Kurdziel, Marta, et al.
Publicado: (2021) -
Paramedic versus physician-staffed ambulances and prehospital delays in the management of patients with ST-segment elevation myocardial infarction
por: Borowicz, Artur, et al.
Publicado: (2021) -
COVID-19 mimicking ST-elevation myocardial infarction
por: Bujak, Kamil, et al.
Publicado: (2020) -
Angiopoietin-2 as a biomarker of non-ST-segment elevation myocardial infarction in patients with or without type 2 diabetes
por: Skowerski, Tomasz, et al.
Publicado: (2019)